Tetrasomy 6 and 6q14 deletion are associated with better survival in hepatocellular carcinomas: A fluorescence in situ hybridization study of 77 cases

Cancer Genetics and Cytogenetics

Volumn 144, Issue 1, 2003, Pages 23-30

  Huang, Shiu Feng ^a   Hsu, Hey Chi ^b   Chen, Jeng Chang ^a   Chie, Wei Chu ^c   Lai, Polin ^b  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ALLELE; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CENTROMERE; CHROMOSOME 6; CHROMOSOME 6Q; CHROMOSOME ARM; CHROMOSOME DELETION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISOMY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE LOSS; GENE PROBE; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; MOLECULAR CLONING; MOLECULAR INTERACTION; PRIORITY JOURNAL; SEX RATIO; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; TETRASOMY; TRISOMY; TUMOR VOLUME; YEAST ARTIFICIAL CHROMOSOME; GENETICS; LIVER TUMOR; MORTALITY;

CARCINOMA, HEPATOCELLULAR; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 6; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LIVER NEOPLASMS; SURVIVAL RATE;

EID: 0038117781     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(02)00860-9     Document Type: Article

References (47)

1. Simmon D., Munoz S.J., Maddrey W.C., Knowles B. Chromosomal rearrangements in a primary hepatocellular carcinoma. Cancer Genet Cytogenet. 45:1990;255-260.
2. Bardi G., Johanson B., Pandis N., Heim S., Mandahl N., Andrén-Sandberg A., Hagerstrand I., Mitelman F. Cytogenetic findings in three primary hepatocellular carcinomas. Cancer Genet Cytogenet. 58:1992;191-195.
3. Werner M., Nolte M., Georgii A., Klempnauer J. Chromosome1 abnormaities in hepatocellular carcinoma. Cancer Genet Cytogenet. 66:1993;130.
4. Chen H.L., Chen Y.C., Chen D.S. Chromosome 1p aberrations are frequent in human primary hepatocellular carcinoma. Cancer Genet Cytogenet. 86:1996;102-106.
5. Lowichik A., Schneider N.R., Tonk V., Ansari M.Q., Timmons C.F. Report of a complex karyotype in recurrent metastatic fibrolamellar hepatocellular carcinoma and a review of hepatocellular carcinoma cytogenetics. Cancer Genet Cytogenet. 88:1996;170-174.
6. Bardi G., Rizou H., Michailakis E., Dietrich C., Pandis N., Heim S. Cytogenetic findings in three primary hepatocellular carcinomas. Cancer Genet Cytogenet. 104:1998;165-166.
7. Parada L.A., Hallén M., Tranberg K.G., Hägerstrand I., Bondeson L., Mitelman F., Johansson B. Frequent rearrangements of chromosomes 1, 7, and 8 in primary liver cancer. Genes Chromosomes Cancer. 23:1998;26-35.
8. Fujimori M., Tokino T., Hino O., Kitagawa T., Imamura T., Okamoto E., Mitsunobu M., Ishikawa T., Nakagama H., Harada H. Allelotype study of primary hepatocellular carcinoma. Cancer Res. 51:1991;89-93.
9. Boige V., Laurent-Puig P., Fouchet P., Fléjou J.F., Monges G., Bedossa P., Bioulac-Sage P., Capron F., Schmitz A., Olschwang S., Thomas G. Concerted nonsyntenic allelic losses in hyperploid hepatocellular carcinoma as determined by a high-resolution allelotype. Cancer Res. 57:1997;1986-1990.
10. Nagai H., Pineau P., Tiollais P., Buendia M.A., Dejean A. Comprehensive allelotyping of human hepatocellular carcinoma. Oncogene. 14:1997;2927-2933.
11. Yeh S.H., Chen P.J., Lai M.Y., Chen D.S. Allelic loss on chromosomes 4q and 16q in hepatocellular carcinoma. association with alpha-fetoprotein production Gastroenterol. 110:1996;184-192.
12. Zhang W., Hirohashi S., Tsuda H., Shimosato Y., Yokota J., Terada M., Sugimura T. Frequent loss of heterozygosity on chromosomes 16 and 4 in human hepatocellular carcinoma. Jpn J Cancer Res. 81:1990;108-111.
13. Emi M., Fujiwara Y., Nakajima T., Tsuchia E., Tsuda H., Hirehashi S., Maeda Y., Tsuruta K., Miyaki M., Nakamura Y. Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer. Cancer Res. 52:1992;5368-5372.
14. Emi M., Fujiwara Y., Ohata H., Tsuda H., Hirohashi S., Koike M., Miyaki M., Monden M., Nakamura Y. Allelic loss at chromosome band 8p21.3-p22 is associated with progression of hepatocellular carcinoma. Genes Chromosomes Cancer. 7:1993;152-157.
15. De Souza A.T., Hankins G.R., Washington M.K., Fine R.L., Orton T.C., Jirtle R.L. Frequent loss of heterozygosity on 6q at the mannose 6-phosphate/insulin like growth factor II receptor locus in human hepatocellular tumors. Oncogene. 10:1995;1725-1729.
16. Wang G., Zhao Y., Liu X., Wang L., Wu C., Zhang W., Liu W.et al. Allelic loss and gain, but not genomic instability, as the major somatic mutatation in primary hepatocellular carcinoma. Genes Chromosomes Cancer. 31:2001;221-227.
17. Marchio A., Meddeb M., Pineau P., Danglot G., Tiollais P., Bernheim A., Dejean A. Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization. Genes Chromosomes Cancer. 18:1997;59-65.
18. Kusano N., Shiraishi K., Kubo K., Oga A., Okita K., Sasaki K. Genetic aberrations detected by comparative genomic hybridization in hepatocellular carcinomas. their relationship to clinicopathological features Hepatology. 29:1999;1858-1862.
19. Wong N., Lai P., Lee S.W., Fan S., Pang E., Liew C.T., Sheng Z., Lau J.W.Y., Johnson P.J. Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis. Relationship to disease stage, tumor size, and cirrhosis. Am J Pathol. 154:1999;37-43.
20. Lin Y.W., Sheu J.C., Huang G.T., Lee H.S., Chen C.H., Wang J.T., Lee Ph Lu F.J. Chromosomal abnormality in hepatocellular carcinoma by comparative genomic hybridization in Taiwan. Eur J Cancer. 35:1999;652-658.
21. Marchio A., Pineau P., Meddeb M., Terris B., Tiollais P., Bernheim A., Dejean A. Distinct chromosomal abnormality pattern in primary liver cancers of non-B, non-C patients. Oncogene. 19:2000;3733-3738.
22. Zimmermann U., Feneux D., Mathey G., Gayral F., Franco D., Bedossa P. Chromosomal aberrations in hepatocellular carcinomas. relationship with pathological features Hepatology. 26:1997;1492-1498.
23. Nasarek A., Werner M., Nolte M., Klempnauer J., Georgii A. Trisomy 1 and 8 occur frequently in hepatocellular carcinoma but not in liver cell adenoma and focal nodular hyperplasia. a fluorescence in situ hybridization study Virchows Arch. 427:1995;373-378.
24. Hamon-Benais C., Ingster O., Terris B., Couturier-Turpin M.H., Berheim A., Feldmann G. Interphase cytogenetic studies of human hepatocellular carcinomas by fluorescence in situ hybridization. Hepatology. 23:1996;429-435.
25. Kimura H., Kagawa K., Deguchi T., Nakajima T., Kakushi M., Okawara T., Katagishi T., Okanoue T., Kashima K., Ashihara T. Cytogenetic analyses of hepatocellular carcinoma by in situ hybridization with a chromosome-specific DNA probe. Cancer. 77:1996;271-277.
26. Ohasawa N., Sakamoto M., Saito T., Kobayashi M., Hirohashi S. Numerical chromosome aberrations in hepatocellular carcinoma detected by fluorescence in situ hybridization. J Hepatol. 25:1996;655-662.
27. Kato A., Kobe K., Kurokawa F., Okita K., Oga A., Murakami T. Numerical aberrations of chromosomes 16, 17, and 18 in hepatocellular carcinoma. a FISH and FCM analysis of 20 cases Dig Dis Sci. 43:1998;1-7.
28. Huang S.F., Hsu H.C., Fletcher J.A. Investigation of chromosomal aberrations in hepatocellular carcinoma by fluorescence in situ hybridization. Cancer Genet Cytogenet. 111:1999;21-27.
29. Mertens F., Johansson B., Höglund M., Mitelman F. Chromosomal imbalance maps of malignant solid tumors. a cytogenetic survey of 3185 neoplasms Cancer Res. 57:1997;2765-2780.
30. Cooney K.A., Wetzel J.C., Consolino C.M., Wojno K.J. Identification and characterization of proximal 6q deletions in prostate cancer. Cancer Res. 56:1996;4150-4153.
31. Bell D.W., Jhanwar S.C., Testa J.R. Multiple regions of allelic loss from chromosome arm 6q in malignant mesothelioma. Cancer Res. 57:1997;4057-4062.
32. Menasce L.P., Orphanos V., Santibanez-Koref M., Boyle J.M., Harrison C.J. Common region of deletion on the long arm of chromosome 6 in non-Hodgkin's lymphoma and acute lymphoblastic leukemia. Genes Chromosomes Cancer. 10:1994;286-288.
33. Kersemaekers A.M.F., Kenter G.G., Hermans J., Fleuren G.J., van de Vijver M.J. Allelic loss and prognosis in carcinoma of the uterine cervix. Int J Cancer. 79:1998;411-417.
34. Huang S.F., Hsu H.C., Cheng Y.M., Chang T.C. Allelic loss at chromosome band 6q14 correlates with favorable prognosis in hepatocellular carcinoma. Cancer Genet Cytogenet. 116:2000;23-27.
35. Simon D., Aden D.P., Knowles B.B. Chromosomes of human hepatoma cell lines. Int J Cancer. 30:1982;27-33.
36. Simon D., Aden D.P., Knowles B.B. Hepatocellular carcinoma cell line and the peripheral blood lymphocytes from the same patient contain common chromosomal alterations. Lab Invest. 55:1986;657-665.
37. Grabovskaya I.L., Tugizov S.M., Glukhova L.A., Kushch A.A. Cytogenetic analysis of human hepatocellular carcinoma cell line PLC-PRF-5 and its mutant clones with different degrees of cell differentiation. Cancer Genet Cytogenet. 65:1993;147-151.
38. Pang E., Wong N., Lai P.B.S., To K.F., Lau J.W.Y., Johnson P. A comprehensive karyotypic analysis on a newly developed hepatocellular carcinoma cell line, HKCI-1, by spectral karyotyping and comparative genomic hybridization. Cancer Genet Cytogenet. 121:2000;9-16.
39. Edmondson H.A., Steiner P.E. Primary carcinoma of the liver. A study of 100 cases among 48900 necropsies. Cancer. 7:1954;462-503.
40. Xiao S., Renshaw A.A., Cibas E.S., Hudson T.J., Fletcher J.A. Novel fluorescence in situ hybridization approaches in solid tumors. characterization of frozen specimens, touch preparations, and cytologic preparations Am J Pathol. 147:1995;896-904.
41. Hopman A.H., Ramaekers F.C., Raap A.K., Beck J.L., Devilee P., van der Ploeg P., Voots G.P. In situ hybridization as a tool to study numerical chromosome aberrations in solid bladder tumors. Histochemistry. 89:1988;307-316.
42. Takahashi S., Qian J., Brown J.A., Alcaraz A., Bostwick D.G., Lieber M.M., Jenkins R. Potential markers of prostate cancer aggressiveness detected by fluorescence in situ hybridization in needle biopsies. Cancer Res. 54:1994;3574-3579.
43. Risques R.A., Moreno V., Marcuello E., Petriz Cancelas J.A., Sancho F.J., Torregrosa A., Capella G., Peinado M.A. Redefining the significance of aneuploidy in the prognostic assessment of colorectal cancer. Lab Invest. 81:2001;307-315.
44. Jhala D.N., Atkinson B.F., Balsara G.R., Hernandez E., Jhala N.C. Role of DNA ploidy analysis in endometrial adenocarcinoma. Ann Diagn Pathol. 5:2001;267-273.
45. Jin Y., Mertens F., Mandahl N., Wennerberg J., Dictor M., Heim S., Mitelman F. Tetrapolization and progressive loss of 6q in a squamous cell carcinoma of the parotid gland. Cancer Genet Cytogenet. 79:1995;157-159.
46. Yan J., Marceau D., Drouin R. Tetrasomy 8 is associated with a major cellular proliferative advantage and a poor prognosis. two cases of myeloid hematologic disorders and review of the literature Cancer Genet Cytogenet. 125:2001;14-20.
47. Maillo A., Diaz P., Sayagues J.M., Blanco A., Tabernero M.D., Ciudad J., Lopez A., Goncalves J.M., Orfao A. Gains of chromosome 22 by fluorescence in situ hybridization in the context of an hyperdiploid karyotype are associated with aggressive clinical features in meningioma patients. Cancer. 92:2001;377-385.